Fulvestrant: An estrogen receptor antagonist

Healthcare professionals recommend using the drug Fulvestrant in the treatment of patients who have HR +Ve metastatic breast cancer in the postmenopausal women with disease progression and HR +Ve, HER2 -Ve advanced breast cancer along with palbociclib in women with disease progression after the therapy of endocrine. Fulvestrant cost is economical, and one can purchase this medicine from generic medicine suppliers.